Zobrazeno 1 - 10
of 71
pro vyhledávání: '"MS therapy"'
Autor:
Lamberto Landete, Francisco Pérez-Miralles, Sara García, Antonio Belenguer, Francisco Gascón, Jose Andres Domínguez, María Carcelén-Gadea, Carlos Quintanilla-Bordás, Laura Navarro, Laura Gabaldón, Bonaventura Casanova
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Introduction: We have different treatment alternatives for relapsing-remitting multiple sclerosis–RRMS–within the so-called platform drugs. It would be desirable to know the ideal drug for each patient. Real clinical practice studies provide us w
Externí odkaz:
https://doaj.org/article/e4c47455c9fb40f4b29c944df0dadf9c
Autor:
Ralf A. Linker, Andrew Chan
Publikováno v:
Neurological Research and Practice, Vol 1, Iss 1, Pp 1-8 (2019)
Abstract Background With the advent of modern immunotherapies for relapsing-remitting multiple sclerosis (RRMS) and the increasing amount of treatment options on the market, MS has evolved as a treatable disease. Yet, at the same time, new challenges
Externí odkaz:
https://doaj.org/article/6d5e6bf2e265424488688f461b4b0010
Autor:
Fred Lühder, Hania Kebir, Francesca Odoardi, Tanja Litke, Maike Sonneck, Jorge Ivan Alvarez, Jan Winchenbach, Nadine Eckert, Liat Hayardeny, Ella Sorani, Dmitri Lodygin, Alexander Flügel, Alexandre Prat
Publikováno v:
Neurobiology of Disease, Vol 102, Iss , Pp 60-69 (2017)
Laquinimod is currently being tested as a therapeutic drug in multiple sclerosis. However, its exact mechanism of action is still under investigation. Tracking of fluorescently-tagged encephalitogenic T cells during experimental autoimmune encephalom
Externí odkaz:
https://doaj.org/article/bb0d65d19072434a88849b414fc214b3
Autor:
Ulges, Alexander, Witsch, Esther J., Pramanik, Gautam, Klein, Matthias, Birkner, Katharina, Bühler, Ulrike, Wasser, Beatrice, Luessi, Felix, Stergiou, Natascha, Dietzen, Sarah, Brühl, Till-Julius, Bohn, Toszka, Bündgen, Georg, Kunz, Horst, Waisman, Ari, Schild, Hansjörg, Schmitt, Edgar, Zipp, Frauke, Bopp, Tobias
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2016 Sep 01. 113(36), 10145-10150.
Externí odkaz:
https://www.jstor.org/stable/26471574
Autor:
Francisco Gascón, Francisco Pérez-Miralles, Sara García, Bonaventura Casanova, Laura Gabaldón, Laura Navarro, Lamberto Landete, Antonio Belenguer, Carlos Quintanilla-Bordás, María Carcelén-Gadea, Jose Andres Dominguez
Publikováno v:
Frontiers in Neurology
Frontiers in neurology
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Frontiers in Neurology, Vol 12 (2021)
Frontiers in neurology
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Frontiers in Neurology, Vol 12 (2021)
Introduction: We have different treatment alternatives for relapsing-remitting multiple sclerosis–RRMS–within the so-called platform drugs. It would be desirable to know the ideal drug for each patient. Real clinical practice studies provide us w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c83214126b01addf3a1d175e95f5b6c
https://pubmed.ncbi.nlm.nih.gov/34803877
https://pubmed.ncbi.nlm.nih.gov/34803877
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 7319, p 7319 (2021)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Multiple sclerosis (MS) is a central nervous system disease with complex pathogenesis, including two main processes: immune-mediated inflammatory demyelination and progressive degeneration with axonal loss. Despite recent progress in our understandin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51dd15270863e98a7274ea58c6b78eaa
https://www.mdpi.com/1422-0067/22/14/7319
https://www.mdpi.com/1422-0067/22/14/7319
Autor:
Landete L, Perez-Miralles F, Garcia S, Belenguer A, Gascon F, Andres Dominguez J, Carcelen-Gadea M, Quintanilla-Bordas C, Navarro L, Gabaldon L, Casanova B
Publikováno v:
Frontiers in Neurology
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
Introduction: We have different treatment alternatives for relapsing-remitting multiple sclerosis-RRMS-within the so-called platform drugs. It would be desirable to know the ideal drug for each patient. Real clinical practice studies provide us with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::131a73c812b21268cc73c01af056f08f
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=12168
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=12168
Autor:
Bruce A.C. Cree, Stephen L. Hauser
Publikováno v:
Am J Med
The American journal of medicine, vol 133, iss 12
The American journal of medicine, vol 133, iss 12
Multiple sclerosis (MS) is an autoimmune demyelinating and neurodegenerative disease of the central nervous system, and the leading cause of non-traumatic neurological disability in young adults. Effective management requires a multifaceted approach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a835096b8919ae8d3290d8032b997fa5
https://pubmed.ncbi.nlm.nih.gov/32682869
https://pubmed.ncbi.nlm.nih.gov/32682869
Autor:
Nadine Eckert, Jorge I. Alvarez, Liat Hayardeny, Alexander Flügel, Francesca Odoardi, Dmitri Lodygin, Fred Lühder, Jan Winchenbach, Tanja Litke, Maike Sonneck, Ella Sorani, Hania Kebir, Alexandre Prat
Publikováno v:
Neurobiology of Disease, Vol 102, Iss, Pp 60-69 (2017)
Laquinimod is currently being tested as a therapeutic drug in multiple sclerosis. However, its exact mechanism of action is still under investigation. Tracking of fluorescently-tagged encephalitogenic T cells during experimental autoimmune encephalom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a79fedef83817484f83a1dfa8f47892
http://www.sciencedirect.com/science/article/pii/S0969996117300311
http://www.sciencedirect.com/science/article/pii/S0969996117300311
Autor:
Gwendoline Montes Diaz
Multiple sclerosis (MS) is a disease that is caused when the patient’s own immune cells attack the central nervous system, i.e. an autoimmune disease. The disease has a prevalence of 1-2.5 million people worldwide, but there is no known cure. Dimet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aed78ba91bbc4a965ac3bda6748d2567
https://cris.maastrichtuniversity.nl/en/publications/5e07e716-eb35-400b-a2a4-a123810af587
https://cris.maastrichtuniversity.nl/en/publications/5e07e716-eb35-400b-a2a4-a123810af587